News

XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.

Klarna keeps sliding weeks after a guidance cut rattled investors, while Affirm moves in the opposite direction as traders rally around its AI underwriting push. The widening gap between two of fintech's biggest names raises a pointed question about which side of this trade holds up.

Micron has been one of the most volatile stocks in the AI trade all year. Something Citi published on September 23 changes how that volatility reads.

Chuck Robbins, the CEO of $415 billion tech company Cisco, urges leaders to not use AI as a “cost-reduction efficiency play” and cut staffers.

Boeing stock fell about 1.5% on Thursday when reports indicated China was probably not place further purchase orders for new jets.

While the S&P 500 is up 18.4% since March 2026, Standex (currently trading at $275.55 per share) has lagged behind, posting a return of 6%. This may have investors wondering how to approach the situation.

MicroStrategy abandoned its original software identity to become a leveraged Bitcoin holding company, and after a brutal 51% collapse over the past year, the question is whether that audacious bet is finally starting to pay off or setting up for something far worse.

PepsiCo (PEP) plans to increase prices on some of its chips, soda and dips, Bloomberg reported Thurs

Holding blue-chip Dow dividend payers in a taxable account quietly hands the IRS a cut of every reinvested dollar, year after year, and the compounding cost over two decades is far steeper than most investors expect.

Starbucks plans to close more unprofitable locations as its turnaround under CEO Brian Niccol continues.

Chief executive Stéphane Bancel shares what’s next for Moderna after its report of a breakthrough of its cancer vaccine. He also discusses the state of the FDA and competition from China, AI integration in the drug industry and bioterrorism readiness.

Rising borrowing costs are hitting solar stocks harder than almost anything else in the market Thursday, and the reasons behind the selloff reveal deeper vulnerabilities across the entire renewable energy sector.

IBM (NYSE: $IBM) is giving banks a new way to use Swift’s blockchain-based ledger to move tokenized deposits....

Qualcomm's Snapdragon Sound Elite Gen 2 brings on-device AI, advanced audio and connectivity to next-generation intelligent wearables.

Sherwin-Williams currently trades at $326.33 per share and has shown little upside over the past six months, posting a middling return of 4%. The stock also fell short of the S&P 500’s 18.4% gain during that period.

Deutsche Bank shares lost 4.5% as Q3'26 IB revenue is expected to be flat to slightly lower, while 2026 NII guidance is raised above prior-stated guidance.

The fast food giant plans to increase its market share with chicken and beverages as it expands those platforms while doubling down on beef.

Mark Zuckerberg's Scale AI deal changed the view of Meta being late to the AI game to outright leading it.

It's been an eventful week for the weight-loss drug company, which continues to impress with its clinical data, and today's move isn't much to worry about.

New York sued the prediction market Polymarket on Thursday, arguing the platform is an unlicensed gambling operation and calling for a judge to block the company from operating in the state. Prediction market platforms have argued states do not have the authority to govern them because they are regulated at the federal level by the U.S. Commodity Futures Trading Commission. New York officials filed Thursday's lawsuit against Polymarket in state court and want the company to face fines and be forced to pay restitution to users because the platform did not get a gaming license from the state.

Warren Buffett recently penned his last letter to Berkshire Hathaway investors as Chairman.

Bank of America just cut UPS to sell, and the catalyst has nothing to do with shipping demand or Amazon competition. The real threat is a regulatory change that turns UPS's fastest, highest-volume lanes into a compliance liability that surcharges alone may not fix.

Exelixis faces a three-month FDA review delay for zanzalintinib, pushing the potential CRC decision to March 2027.

International Business Machines expands its Marist University partnership with an AI Innovation Incubator, bringing mainframe, quantum computing and enterprise expertise to campus.

BlackRock (NYSE: $BLK) is moving three of its investment portfolios onto the blockchain, giving investors a new way...

Chip stocks fell along with the broader market on Thursday as the U.S. and China held trade talks in Washington, D.C.

Neocloud is reshaping AI infrastructure as demand surges. These three ETFs offer targeted exposure while reducing single-stock volatility.

AFRM has entered fiscal 2027 with strong GMV growth and improving margins, but funding costs and credit performance will test its path to sustained profitability.

Glaukos' iDose and Epioxa are driving growth, while recurring treatments, high margins and a broad pipeline support its long-term prospects.

Quantum Computing's Fab 2 adds semiconductor, nanophotonics and advanced packaging capabilities that could accelerate quantum and photonics commercialization.